As of 2026-10-23, the Fair Value of Intellia Therapeutics Inc (NTLA) is -14.31 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 11.16 USD, the upside of Intellia Therapeutics Inc is -228.26%.
With the market price of 11.16 USD and our fair value calculation, Intellia Therapeutics Inc (NTLA) is not a good investment. Investing in NTLA stocks now will result in a potential loss of 228.26%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -267.89 | -474.19 | -481.19 | -519.02 | -412.69 | -431.00 |
| YoY growth | -99.58% | -77.01% | -1.48% | -7.86% | 20.49% | -33.09% |
| Market Cap (mil) | 1,559.28 |
| P/E | |
| Forward P/E |
| EPS | -2.86 |
| Avg earnings growth rate | -33.09% |
| TTM earnings | -399.98 |